New developments for geno2pheno Prof. Nico Pfeifer Uni Tbingen - - PowerPoint PPT Presentation

new developments for geno2pheno
SMART_READER_LITE
LIVE PREVIEW

New developments for geno2pheno Prof. Nico Pfeifer Uni Tbingen - - PowerPoint PPT Presentation

New developments for geno2pheno Prof. Nico Pfeifer Uni Tbingen Excellence cluster: Machine Learning: New Perspectives for Science (Tbingen) 3 Biomedical Data Science Biomedical Data Science Coding skills are necessary for working


slide-1
SLIDE 1

New developments for geno2pheno

  • Prof. Nico Pfeifer

Uni Tübingen

slide-2
SLIDE 2

Excellence cluster: “Machine Learning: New Perspectives for Science” (Tübingen)

3

slide-3
SLIDE 3

Biomedical Data Science

slide-4
SLIDE 4

Biomedical Data Science

5

Coding Skills

Coding skills are necessary for working with massive amounts of electronic data that must be acquired, cleaned, and manipulated.

slide-5
SLIDE 5

As transformative as electricity was?

slide-6
SLIDE 6

Nature (2017) doi:10.1038/nature21056

~130,000 labeled images to train the model

slide-7
SLIDE 7

Machine Learning

  • What can Machine Learning methods

solve? –“Everything “

slide-8
SLIDE 8

Machine Learning

  • What can Machine Learning methods

solve? –Andrew Ng: “Everything a human can do in a second” (low hanging fruits)

  • Automation of certain processes

– Classification: Spam / no spam – Scene understanding: object recognition in pictures/videos – Text translation: English – German – Predict wait times: Pizza delivery

slide-9
SLIDE 9

Machine Learning in Medicine

  • What could Machine Learning methods

solve (harder cases)? –Predict therapy success

  • Complex data, but simple phenotype (e.g.,

therapy success / failure)

  • Find predictors in complex data to predict

success or failure early during course of the disease

  • Provide interpretable results for treatment

decision support

slide-10
SLIDE 10

Treatment Decision Support System (TDSS) for HIV- infected patients

  • T. Lengauer, N. Pfeifer, R. Kaiser, Personalized HIV therapy to

control drug resistance. Drug Discov. Today Technol. 11, 57–64 (2014).

  • Prime example of

personalized medicine:

  • Many different drugs

available

  • Drugs are given in

combination (>2)

  • Drug resistance mainly

depends on genotype of virus (small genome)

  • Large data collections have

been established to enable training the machine learning algorithms (AREVIR, EuResist, ...)

slide-11
SLIDE 11

If we have NGS data

12

https://ngs.geno2pheno.org/

slide-12
SLIDE 12

Treatment decision support systems for NGS data from HIV/HCV

13

Döring M., …, Rolf Kaise, Thomas Lengauer, and Pfeifer N. Nucleic Acids Research 2018, gky349

slide-13
SLIDE 13

Treatment decision support systems for NGS data

14

https://ngs.geno2pheno.org/

slide-14
SLIDE 14

Server for HIV resistance prediction against bNAbs

15

geno2pheno[bNAbs]

slide-15
SLIDE 15

Based on

16 http://journals.plos.org/ploscompbiol/issue?id=10.1371/issue.pcbi.v13.i11#Cover

  • A. Hake and N. Pfeifer,

PLOS Computational Biology 2017, 13(10):e1005789

slide-16
SLIDE 16

Estimated tuberculosis cases and deaths, 2017: Estimated mortality of TB cases (all forms, excluding HIV) per 100,000 population

17

slide-17
SLIDE 17

Notified MDR/RR-TB Cases absolute numbers

18

slide-18
SLIDE 18
  • Project runs for 2 years
  • brings together 12 partners from 10 countries

that are led by EuResist Network (Italy).

  • Centre of Excellence for Health, Immunity and

Infections (CHIP, Denmark) is responsible for scientific coordination of the project.

  • CARE operates under a specific Horizon 2020

call aiming to foster research between the EU and the Russian Federation.

19

slide-19
SLIDE 19

20

Kick off meeting in Rome 1/2019

slide-20
SLIDE 20

Kick off meeting in Rome 1/2019

21

slide-21
SLIDE 21

Geno2pheno[TB]

  • Start with existing data / existing rules

– Collaboration with Borstel (Leibniz Center for Medicine and Biosciences)

  • Build customized version for Eastern

Europe

– Transfer Learning with general model and newly generated data from St. Petersburg and Chisinau

22

slide-22
SLIDE 22

Future of geno2pheno

  • [ngs-freq]: Predict treatment success from NGS data

directly

– Use linkage information between positions for more accurate models – Get rid of “expert” cut-offs – Differentiate functional from non-functional viral variants

  • [ngs-freq]: Include host information

– Some HLA footprints overlap with positions predictive for treatment success

  • [bNAbs]: Optimize for clinical use case
  • Prediction methods for other diseases: TB, HCV, …

26

slide-23
SLIDE 23

Treatment decision support systems

  • More and more data can be measured

(e.g., different omics layers)

  • Data is available for more and more

diseases (see medical informatics initiative)

  • We need efficient machine learning / data

mining methods to learn association between treatment and patient outcome

  • Results need to be communicated in a

transparent and interpretable form

slide-24
SLIDE 24

Thanks to everybody, especially:

Thomas Lengauer Rolf Kaiser Francesca Incardona Florian Klein Till Schoofs Jan Heyckendorf Matthias Döring Anna Hake Joachim Büch Georg Friedrich Marius Herr

Come visit us at our new place